Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
JAMA Oncology
|
November 6, 2015
Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection
Julie E Bauman, Jennifer Grandis
Cancer Journal (Sudbury, Mass.)
|
September 27, 2022
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer
Sara M Centuori, Julie E Bauman
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2022
Expert opinion: Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman
Beth M Beadle, Julie E Bauman
Cancer
|
November 14, 2013
Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer
Julie E Bauman, Robert L Ferris
Cancer Prevention Research (Philadelphia, Pa.)
|
August 20, 2017
When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials
Daniel E Johnson, Julie E Bauman
The Journal of Clinical Investigation
|
May 20, 2014
Targeting secondary immune responses to cetuximab: CD137 and the outside story
Julie E Bauman, Jennifer R Grandis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2014
CHK it out! Blocking WEE kinase routs TP53 mutant cancer
Julie E Bauman, Christine H Chung
Oral and Maxillofacial Surgery Clinics of North America
|
November 20, 2018
Current Concepts in Chemotherapy for Head and Neck Cancer
Simran K Sindhu, Julie E Bauman
JAMA Oncology
|
July 31, 2015
Persistent Salivary Human Papillomavirus DNA as a Surveillance Biomarker: Not Just Spitting in the Wind
Julie E Bauman, Robert L Ferris
Cancers
|
December 10, 2021
Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
Ricklie Julian, Malvi Savani, Julie E Bauman
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
JAMA Oncology
|
November 6, 2015
Oral Cancer Chemoprevention--The End of EPOC, the Beginning of an Epoch of Molecular Selection
Julie E Bauman, Jennifer Grandis
Cancer Journal (Sudbury, Mass.)
|
September 27, 2022
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer
Sara M Centuori, Julie E Bauman
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2022
Expert opinion: Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman
Beth M Beadle, Julie E Bauman
Cancer
|
November 14, 2013
Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer
Julie E Bauman, Robert L Ferris
Cancer Prevention Research (Philadelphia, Pa.)
|
August 20, 2017
When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials
Daniel E Johnson, Julie E Bauman
The Journal of Clinical Investigation
|
May 20, 2014
Targeting secondary immune responses to cetuximab: CD137 and the outside story
Julie E Bauman, Jennifer R Grandis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2014
CHK it out! Blocking WEE kinase routs TP53 mutant cancer
Julie E Bauman, Christine H Chung
Oral and Maxillofacial Surgery Clinics of North America
|
November 20, 2018
Current Concepts in Chemotherapy for Head and Neck Cancer
Simran K Sindhu, Julie E Bauman
JAMA Oncology
|
July 31, 2015
Persistent Salivary Human Papillomavirus DNA as a Surveillance Biomarker: Not Just Spitting in the Wind
Julie E Bauman, Robert L Ferris
Cancers
|
December 10, 2021
Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
Ricklie Julian, Malvi Savani, Julie E Bauman
Page
of 11